Global Bio Conference in Seoul

Overview

The 12th Global Bio Conference (GBC) in Seoul, hosted by the Ministry of Food and Drug Safety (MFDS), focuses on the theme ‘Bio Leap, Accelerating Innovation’. The event gathers approximately 5,000 experts from academia, the pharmaceutical industry, and global regulatory authorities to discuss technological trends, including artificial intelligence and advanced biopharmaceuticals.

A primary objective of the MFDS is to accelerate drug approval timelines, aiming to reduce the average review period from 420 days to 240 days by increasing professional staffing and improving communication with industry players.

During the conference, industry experts, including representatives from Dong-A ST, have advocated for ‘regulatory co-development’. This strategy encourages regulatory agencies to engage with companies during the early stages of drug development to ensure that new scientific strategies align with regulatory expectations.

Entities

Seoul · Ministry of Food and Drug Safety · Global Bio Conference · World Health Organization · Cebu

Timeline

1 day ago

[BUSINESS] 2 sources
Global Bio Conference in Seoul focuses on regulatory innovation
The 12th Global Bio Conference in Seoul focuses on accelerating biopharmaceutical innovation through regulatory cooperation, AI integration, and efforts to shorten drug approval timelines.
3 days ago

[INTERNATIONAL] 2 sources
Global summits focus on digital integration in Cebu and biopharma innovation in Seoul
Business and science summits in Cebu and Seoul focus on digital system integration and biopharmaceutical innovation, respectively, highlighting the role of technology in regional and global growth.

Sources

cebudailynews.inquirer.net · healthmedia.co.kr · koreaherald.com · thebionews.net